1443243-76-2

Upstream product

• 1443242-57-6 2,2,2-trifluoro-N-[(S)‐4‐carbonyl-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide 
• 1443242-81-6 (1S,4R)-4-(3-piperidin1-yl-[1,2,4] triazolo[4,3-a]pyridin-6-yloxy)-cis-1,2,3,4-tetrahydro-naphthalen-1-ylamine 
• 1443242-79-2 6-fluoro-3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridine 
• 13939-69-0 piperidine carbamoyl chloride 
• 1443242-76-9 piperidine-1-carboxylic acid N'-(5-fluoro-pyridin-2-yl)-hydrazide 
• 1443239-96-0 1-[5-tert-butyl-2-(3-hydroxymethyl-phenyl)-2H-pyrazol-3-yl]-3-[(1S,4R)-4-(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalen-1-yl]-urea 
• 1443243-46-6 [5-tert-butyl-2-(3-hydroxymethyl-phenyl)-2H-pyrazol-3-yl]-carbamic acid 2,2,2-trichloro-ethyl ester 
• 725686-00-0 [3-(5-amino-3-tert-butyl-pyrazol-1-yl)-phenyl]-methanol 
• 59997-51-2 trimethylacetylacetonitrile 
• 38235-71-1 3-hydrazinobenzoic acid 
• 725685-92-7 3-(5-amino-3-tert-butyl-pyrazol-1-yl)-benzoic acid ethyl ester 
• 1351997-20-0 (1R,4S)-aminoN-(S)-4-hydroxy-1,2,3,4-tetrahydronaphthalen-1-ol 
• 1443242-59-8 2,2,2-trifluoro-N-((1S,4R)-4-hydroxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-acetamide 
• 23357-52-0 (S)-1,2,3,4-tetrahydronapht-1-yl-amine 

Downstream Products

• 1443240-18-3 1-{5-tert-butyl-2-[3-(2-hydroxy-ethoxymethyl)-phenyl]-2H-pyrazol-3-yl}-3-[(1S,4R)-4-(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalen-1-yl]-urea 
• 1443240-20-7 1-(5-tert-butyl-2-{3-[4-(2-hydroxy-ethyl)-piperazin-1-ylmethyl]-phenyl}-2H-pyrazol-3-yl)-3-[(1S,4R)-4-(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalen-1-yl]-urea 
• 1443240-22-9 1-{5-tert-butyl-2-[3-(4-hydroxy-piperidin-1-ylmethyl)-phenyl]-2H-pyrazol-3-yl}-3-[(1S,4R)-4-(3-piperidin-1-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-l,2,3,4-tetrahydro-naphthalen-1-yl]-urea 

Relevant academic research and scientific papers

KINASE INHIBITORS

Compounds of formula (I) or a pharmaceutically acceptable salt thereof: formula (I) wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.